WeVote
Log In

Bill

Bill

A 4604

Relates to creating a wholesale prescription drug importation program

2025 Regular Session Introduced by Alex Bores and 38 co-sponsors

New York bill authorizes wholesale prescription drug importation from other countries to reduce medication costs through state-regulated price arbitrage programs.

REFERENCE CHANGED TO HIGHER EDUCATION
0
WeVote Research Nonpartisan
Bill Summary · A 4604

Legislative bill overview

Bill A 4604 establishes a wholesale prescription drug importation program in New York, allowing the state to import FDA-approved prescription drugs from other countries (primarily Canada) at lower prices for resale to wholesalers and pharmacies. The program aims to reduce medication costs for New York residents by leveraging price differentials between the U.S. and other developed nations.

Why is this important

Prescription drug costs in the United States are significantly higher than in other developed countries, creating a substantial financial burden on patients and the state healthcare system. A successful importation program could reduce out-of-pocket medication expenses and lower overall healthcare spending, though implementation depends on federal approval and regulatory compliance.

Potential points of contention

  • Federal authority concerns: Drug importation programs require federal FDA and Department of Health and Human Services approval; state-level programs may face legal challenges under existing federal law that generally prohibits prescription drug re-importation
  • Pharmaceutical industry opposition: Drug manufacturers typically oppose importation programs as they reduce profit margins and may argue it undermines research funding and intellectual property protections
  • Supply chain safety: Critics raise questions about verifying drug authenticity, maintaining cold chain requirements, and ensuring pharmaceutical quality standards across international borders despite FDA oversight claims
  • Program feasibility: Questions remain about administrative costs, pricing negotiations with foreign suppliers, and whether savings would materialize given regulatory requirements and operational overhead

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.